Skip to main content

Table 2 Perioperative, pathological, and oncological outcomes

From: Application of hyaluronic acid/carboxymethyl cellulose membrane for early continence after nerve-sparing robot-assisted radical prostatectomy

 

Bilateral nerve-sparing RARP (n = 46)

Unilateral nerve-sparing RARP (n = 137)

With HA/CMC (n = 13)

Without HA/CMC (n = 33)

P value

With HA/CMC (n = 40)

Without HA/CMC (n = 97)

P value

Follow-up period, months: median (IQR)

20.7 (16.3–27.0)

20.1 (14.9–29.4)

0.83

21.6 (16.7–27.0)

20.3 (13.3–28.5)

0.79

Operating time, min: median (IQR)

207 (178–223)

215 (189–249)

0.10

210 (176–234)

233 (203–275)

0.09

Estimated blood loss, mL: median (IQR)

10 (2.5–125)

20 (5–125)

0.09

19 (0–88)

70 (0–105)

0.07

Complications ≥ Clavien G3, n (%)

1 (7.7)

3 (9.1)

0.32

1 (2.5)

2 (2.1)

0.87

Urine leakage at cystography, n (%)

1 (7.7)

3 (9.1)

0.81

4 (10.0)

10 (10.3)

0.96

pT, n (%)

  

0.81

  

0.38

pT2

12 (92.3)

28 (84.8)

 

29 (72.5)

77 (79.4)

 

≥ pT3

1 (7.7)

5 (15.2)

 

11 (27.5)

20 (20.6)

 

Gleason sum, n (%)

  

0.48

  

0.50

6

4 (30.8)

7 (21.2)

 

1 (2.5)

3 (3.1)

 

7

7 (53.8)

23 (30.4)

 

31 (77.5)

85 (87.6)

 

≥8

2 (15.4)

3 (9.1)

 

8 (20.0)

9 (9.3)

 

Positive surgical margin, n (%)

2 (15.4)

3 (9.1)

0.54

5 (12.5)

15 (15.5)

0.37

Biochemical failure, n (%)

0 (0)

0 (0)

2 (5.0)

6 (6.2)

0.79